BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DEMENTIA RESEARCHER - ECPv6.14.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DEMENTIA RESEARCHER
X-ORIGINAL-URL:https://www.dementiaresearcher.nihr.ac.uk
X-WR-CALDESC:Events for DEMENTIA RESEARCHER
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260408T200000
DTEND;TZID=Europe/London:20260408T204500
DTSTAMP:20260404T182037
CREATED:20260223T095900Z
LAST-MODIFIED:20260223T095900Z
UID:10002123-1775678400-1775681100@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Research Showcase - Music\, Mathematics and the Ageing Brain
DESCRIPTION:What can music tell us about how the brain adapts to ageing and neurodegeneration. And how can mathematics help us understand those changes. \nThis livestream is part of the Dementia Researcher weekly Showcase series. Each week we host a 45 minute online session bringing researchers together to share their work\, methods\, and ideas. \nIn this session\, Dr Sarah Faber will introduce her work as a computational neuroscientist exploring how the brain adapts to ageing and neurodegeneration. Using music as a core investigative tool alongside advanced mathematical and modelling approaches\, her research examines how brain networks reorganise in response to change. \nDrawing on her multidisciplinary background in neuroscience\, music\, and quantitative methods\, Sarah will discuss how computational neuroscience can reveal patterns of adaptation in the ageing brain\, and what music based paradigms can teach us about resilience and vulnerability. \nAttendees can expect an engaging research focused talk with time for questions and discussion. \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/research-showcase-music-mathematics-and-the-ageing-brain/
LOCATION:Dementia Researcher Communities App
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/02/Music-Mathematics-and-the-Ageing-Brain-web.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260409
DTEND;VALUE=DATE:20260410
DTSTAMP:20260404T182037
CREATED:20260213T105034Z
LAST-MODIFIED:20260213T105034Z
UID:10002106-1775692800-1775779199@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Dementia Research Network Ireland ECR Day
DESCRIPTION:DRNI’s annual Early Career Researcher Day is back! DRNI ECR Day 2026 is taking place in the Human Biology Building\, University of Galway\, on Thursday\, 09 April 2026. \nThis is an in-person event\, and is a free event and open to all! \nDRNI ECR Day is a great opportunity for ECRs from across the island of Ireland to present their research\, meet their peers\, network with other researchers\, and become more familiar with the dementia research landscape in Ireland. It is open to all disciplines\, and will be an in-person event. \nTo register to attend\, or to apply to present your research\, please go to: DRNI ECR Day 2026 Registration Form – Fill out form \nPresentation applications \nDRNI welcomes applications for oral and poster presentations. All application abstracts should be no longer than 150 words\, and use headings such as Introduction\, Methods\, Results\, Conclusion. All applications must be made under one of three themes: \n\nTheme 1 – Dementia risk reduction and prevention\nTheme 2 – The lived experience of dementia and quality of life\nTheme 3 – Therapeutics and diagnostic pathways\n\nAs part of DRNI’s commitment to Person and Public Involvement (PPI) in research\, we will be awarding a prize for PPI engagement at the event. If you would like to be considered for this prize\, there is additional space on the registration form to outline how your research incorporates PPI (world limit 75 words). \nThe deadline for abstract submissions is Friday\, 27th February 2026. \nThere are a limited number of travel bursaries available to help with travel costs – if you are interested\, please tick the relevant box in the registration form. \nIf you have any questions about this in-person event\, please contact Vanessa: mooreva@tcd.ie. \n 
URL:https://www.dementiaresearcher.nihr.ac.uk/event/dementia-research-network-ireland-ecr-day/
LOCATION:University of Galway\, University Rd\, Galway\, Ireland
CATEGORIES:Training
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2023/08/Dementia-Research-Network-Ireland-logo.png
ORGANIZER;CN="Dementia Research Network Ireland":MAILTO:mooreva@tcd.ie
GEO:53.276035;-9.0595869
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=University of Galway University Rd Galway Ireland;X-APPLE-RADIUS=500;X-TITLE=University Rd:geo:-9.0595869,53.276035
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260409
DTEND;VALUE=DATE:20260411
DTSTAMP:20260404T182037
CREATED:20260113T215051Z
LAST-MODIFIED:20260113T215051Z
UID:10002046-1775692800-1775865599@www.dementiaresearcher.nihr.ac.uk
SUMMARY:DSAD - ASAD Conference
DESCRIPTION:This is the third edition of this groundbreaking conference\, which aims to foster collaboration and knowledge exchange between the fields of Down Syndrome associated Alzheimer disease (DSAD) and autosomal dominant AD (ADAD). \nThe event will feature research findings\, clinical trials\, and more\, with an inclusive approach to diversity\, representation\, and accessibility. \n\n\n\n\nThis conference will be a seminal event in advancing the understanding and treatment of Alzheimer’s disease (AD)\, particularly by bridging the fields of Down Syndrome Alzheimer’s disease (DSAD) and Autosomal Dominant Alzheimer’s disease (ADAD). It emphasizes collaboration\, ethical considerations\, and inclusivity\, fostering a unified approach to tackling both conditions. \nA key focus of the conference will be creating lasting networks and collaborations\, ensuring that the dialogue and progress continue well beyond the event itself. Building on the success of the previous conferences\, which attracted close to 200 in-person attendees and many more online from over 20 countries\, this third conference aims to expand on that momentum. In addition to the strong support from the DSAD research community\, we have renowned international ADAD speakers\, with outreach through the DIAN network. The event will promote cross-fertilization of ideas\, highlighting the potential for shared insights between these genetically determined forms of AD. This is particularly timely as we now have several ongoing drug development projects in both DSAD and ADAD\, with more planned. The exchange of ideas between researchers in these areas is crucial for maximizing the impact of therapeutic strategies. \nIn conclusion\, the conference will cultivate a collaborative\, diverse\, and inclusive environment to advance research in DSAD and ADAD. The collective expertise of the organizing and scientific committee\, combined with support from key stakeholders in Alzheimer’s research\, will ensure a successful and impactful event. This gathering represents a significant step forward in global AD research\, providing a dynamic platform that fosters connections\, innovation\, and progress in understanding and treating these intertwined conditions. \nAttendees\, Inclusivity & Collaboration Strategy to promote Diversity\, Equity\, and Inclusion: \n\nIntended Audience: Targeting a diverse group of students\, researchers\, clinicians\, experts\, policy-makers\, and other stakeholders interested in genetically determined AD.\nSelection Process & Inclusivity: Striving for a balanced and diverse program\, selecting top communications from a wide range of contributors.\nGender Balance & Ethnic and Geographical Diversity: Aiming for balanced representation of gender among speakers\, moderators\, and attendees. Actively promoting participation from various ethnic backgrounds and geographical regions.\nEarly and Senior Researchers: Ensuring a mix of early-career and senior researchers in all sessions.\nSupport for Attendees with Families: Provision of daycare services to support those with childcare responsibilities and enable their attendance.\n\nFind out More
URL:https://www.dementiaresearcher.nihr.ac.uk/event/dsad-asad-conference/
LOCATION:Modernist Hospital of Sant Pau\, Sant Antoni Maria Claret Street\, 16\, Barcelona\, Spain
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/01/DSAD-ADAD.png
GEO:41.4031935;2.1639358
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Modernist Hospital of Sant Pau Sant Antoni Maria Claret Street 16 Barcelona Spain;X-APPLE-RADIUS=500;X-TITLE=Sant Antoni Maria Claret Street\, 16:geo:2.1639358,41.4031935
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260409T020000
DTEND;TZID=Europe/London:20260409T150000
DTSTAMP:20260404T182037
CREATED:20260313T201037Z
LAST-MODIFIED:20260310T201401Z
UID:10002148-1775700000-1775746800@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Perspectives on FTD and Care in India
DESCRIPTION:Join the ISTAART Frontotemporal Dementia and Related Disorders Professional Interest Area (PIAs) for a webinar\, Perspectives on FTD and Care in India. This webinar will present a clinically grounded overview of FTD in India\, focusing on how the disease is currently recognized\, characterized and managed across different clinical settings. \nSign up here and join us on Thursday\, April 9\, 2026 at 8 a.m. C.T.  \nModerator: \n\nSwetha Mohan\, Ph.D.; Madrone Biosciences LLC\, United States\n\nSpeakers: \n\nAtri Chatterjee\, M.D.\, Vardhman Mahavir Medical College and Safdarjung Hospital\, India\nRatnavalli Ellajosyula\, M.D.; Manipal Hospital and Annasawmy Mudaliar Hospital\, India\nSoumya Hegde\, MBBS\, DPM\, MRCPych\, CCT; Memory Matters\, India\nRamshekhar N. Menon\, M.D.\, DNB; DM; Sree Chitra Tirunal Institute for Medical Sciences and Technology\, Trivandrum\, India\n\n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/perspectives-on-ftd-and-care-in-india/
LOCATION:Online\, United Kingdom
CATEGORIES:Online
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2023/01/ISTAART-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260409T140000
DTEND;TZID=Europe/London:20260409T153000
DTSTAMP:20260404T182037
CREATED:20260327T120904Z
LAST-MODIFIED:20260327T120904Z
UID:10002168-1775743200-1775748600@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Biomarkers: health system implementation
DESCRIPTION:WDC virtual dialogue \n\n\n\n\nRapid scientific progress in plasma biomarkers is transforming the possibilities for earlier and more accessible diagnosis of Alzheimer’s disease. Yet translating these advances into routine clinical practice presents significant challenges\, including demonstrating clinical utility\, integrating testing into existing care pathways\, and ensuring that health systems are prepared for wider use. \nChaired by Dr Fiona Carragher\, Chief Policy and Research Officer at the Alzheimer’s Association\, the meeting will feature opening presentations from Professor Vanessa Raymont of the University of Oxford and Professor Jeff Burns of the University of Kansas\, followed by a round-table discussion. Additional speakers will be announced. The dialogue will explore how emerging biomarker technologies can move from research settings into real-world health systems and what evidence\, infrastructure\, and policy changes are required to support their effective adoption. \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/biomarkers-health-system-implementation/
LOCATION:Online\, United Kingdom
CATEGORIES:Workshop
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2020/12/World-Dementia-Council.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260409T163000
DTEND;TZID=Europe/London:20260409T230000
DTSTAMP:20260404T182037
CREATED:20260401T144837Z
LAST-MODIFIED:20260401T144837Z
UID:10002176-1775752200-1775775600@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Synuclein Biomarkers & Neuropathology Summit 2026
DESCRIPTION:Join co-chairs\, Dr. Robert Rissman and Dr Nicholas Ashton for a focused scientific summit bringing together leading investigators\, clinicians\, and translational researchers to advance the future of synuclein biomarker development. This meeting will spotlight emerging hypotheses\, active research programs\, and key challenges limiting antemortem detection across Alzheimer’s disease–related dementias and movement disorders. \n\n\nThrough expert-led discussions\, the summit aims to deepen understanding of synuclein pathology\, ongoing therapeutic trials\, and biomarker strategies to help accelerate earlier\, more accurate detection. \n\n\nagenda\n\n\nThursday\, April 9\n9:00 am-4:30 pm: Main Session \nKEYNOTE PRESENTATION\nMajor Hypotheses in Synuclein Research Alzheimers Disease & Parkinsons Disease\nLea Grinberg\, MD\, PhD – Mayo Clinic \nSession 1 (panel discussion): Clinical Standards for Synuclein\nModerator: Robert Rissman\, PhD – Epstein Family ATRI\, USC\nPanelists:\nPaul Aisen\, MD – Epstein Family ATRI\, USC\nAmy Kind\, MD\, PhD – University of Wisconsin\nJames Leverenz\, MD – University of Washington\nAhmad Sajjadi\, MD – UC Irvine School of Medicine\n\nSession 2: Synuclein (detecting and treating)\nModerator: Nicholas Ashton\, PhD – Banner Health\nSpeakers:\nBrian Spencer\, PhD – Epstein Family ATRI\, USC\nPam J. Mclean\, PhD – Mayo Clinic\nDuygu Tosun-Turgut\, PhD – UCSF\nHartmuth Kolb\, PhD – Enigma Biomedical USA\n\nSession 3: Synuclein Proteomics\nModerator: Steve Williams\, MD\, PhD – Alamar Biosciences\nSpeakers:\nCarlos Cruchaga\, PhD – Washington University School of Medicine\nNicholas Ashton\, PhD – Banner Health\nNicolas T. Seyfried\, PhD – Emory University School of Medicine\n\nSession 4 (panel discussion): Biomarker Therapeutics\nModerator: Sterling Johnson\, PhD – University of Wisconsin\nPanelists:\nJoel Mathews\, PhD – Ionis\nSteve Williams\, MD\, PhD – Alamar Biosciences\nLuis Concha\, PhD – Amprion\nCharbel Moussa\, MBBS\, PhD – Georgetown University Medical Center\n\nSession 5 (panel discussion): Future Directions\nModerator: Nicholas Ashton & Robert Rissman\nPanelists:\nLea Grinberg\, MD\, PhD – Mayo Clinic\nSterling Johnson\, PhD – University of Wisconsin\nSusan Landau\, PhD – UC Berkeley\nSteve Williams\, MD\, PhD – Alamar Biosciences\n \n4:30 pm: Closing Remarks & Adjourn \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/synuclein-biomarkers-neuropathology-summit-2026/
LOCATION:Online\, United Kingdom
CATEGORIES:Summit
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2025/09/Alamar-Biosciences-virtual-ARGOnaut-Club-Voyager-Summit-2025.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260409T190000
DTEND;TZID=Europe/London:20260409T200000
DTSTAMP:20260404T182037
CREATED:20260313T150026Z
LAST-MODIFIED:20260311T153926Z
UID:10002149-1775761200-1775764800@www.dementiaresearcher.nihr.ac.uk
SUMMARY:ISTAART Neuroscience Mentoring Club
DESCRIPTION:The ISTAART Alliance of Women Alzheimer’s Researchers (AWARE) and Immunity and Neurodegeneration PIAs invite you to join the next ISTAART Neuroscience Mentoring Club.  \nISTAART Neuroscience Mentoring Clubs are informal virtual meetings that aim to create a relaxed\, confidential space for junior and senior PIA members to connect\, exchange ideas and share perspectives. These sessions aim to stimulate collaboration\, foster mentorship and facilitate interaction between members from all backgrounds and career stages. \nISTAART Neuroscience Mentoring Clubs are not recorded\, allowing for open dialogue and feedback. \nSign up here to join us on Thursday\, April 9\, 2026\, at 1 p.m. C.T. \nSpeaker: \n\nColleen Rosemarie Zaccard\, Ph.D.\, Northwestern University\n\nModerator: \n\nAngela Gomez Arboledas\, Ph.D.\, University of California\, Irvine\n\n\nRegister\n  \nIf you are not a member of one of these PIAs\, we invite you to join today to stay informed. See this guide for details on joining a PIA. 
URL:https://www.dementiaresearcher.nihr.ac.uk/event/istaart-neuroscience-mentoring-club-2/
LOCATION:Online\, United Kingdom
CATEGORIES:Online
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2023/01/ISTAART-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260410T080000
DTEND;TZID=Europe/London:20260410T090000
DTSTAMP:20260404T182037
CREATED:20260323T091014Z
LAST-MODIFIED:20260323T091014Z
UID:10002154-1775808000-1775811600@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Designing Clinical Trials for Dementia-Risk Cohorts
DESCRIPTION:Register for the Workshop: Designing Clinical Trials for Dementia-Risk Cohorts: Practical Strategies for Success \nThursday 10 April 2026\, 9:00 – 10:30AM CEST \nRegister your details below before April 1. Please be aware that number of participants is limited. We will send the Zoom meeting details to selected participants before April 7.  Please note that this workshop will be delivered in English language. \nConducted in partnership with: Jena University Hospital (Germany)\, Vilnius University (Lithuania)\, Rīga Stradiņš University (Latvia)\, Western Sydney University (Australia). \nWhat you’ll learn: \n\nClinical trial design choices\nCognitive & functional endpoints that balance sensitivity and burden\nDecentralised vs. onsite trade-offs\, biosample & neuroimaging workflows\nPiloting/feasibility methods and mixed‑methods to boost recruitment & retention\n\nIdeal for investigators planning early‑phase or prevention trials. \nFacilitated by: A/Prof Genevieve Steiner-Lim\, Najwa-Joelle Metri\, Lauren Dewsbury & Rose Mery Bou Merhy. \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/designing-clinical-trials-for-dementia-risk-cohorts/
LOCATION:Online\, United Kingdom
CATEGORIES:Online
ATTACH;FMTTYPE=image/jpeg:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/03/1774003275801-e1774256950717.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260410T120000
DTEND;TZID=Europe/London:20260410T130000
DTSTAMP:20260404T182037
CREATED:20260206T120220Z
LAST-MODIFIED:20260206T120220Z
UID:10002088-1775822400-1775826000@www.dementiaresearcher.nihr.ac.uk
SUMMARY:PPA Awareness Day 2026 Webinar
DESCRIPTION:Primary Progressive Aphasia (PPA) is a rare language led dementia. People with PPA have told us that it can be difficult to get an accurate diagnosis and to get the right support. \nThe 2026 awareness campaign aims to increase knowledge about PPA and what the right supports might be\, and this year is delivered is a collaboration with the Royal College of Speech and Language Therapists\, Rare Dementia Support and the Memory Services National Accreditation Programme (MSNAP). MSNAP is a quality improvement network under the Royal College of Psychiatrists that accredits UK dementia services. \nThe campaign will run for 10-weeks. Each Friday we will share news\, personal anecdotes from people with lived experience or updates on research via social media. \nThe campaign will culminate in a webinar at midday on PPA Awareness Day – Friday 10th April. \nThe webinar is for everyone and will include short presentations from: \n\na world leading neurologist\nspeech and language therapists\nrepresentatives from Rare Dementia Support and MSNAP\npeople with lived experience\n\nRegister to Attend
URL:https://www.dementiaresearcher.nihr.ac.uk/event/ppa-awareness-day-2026-webinar/
LOCATION:Online\, United Kingdom
CATEGORIES:Online
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2025/02/Primary-Progressive-Aphasia-Awareness-Day.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260413
DTEND;VALUE=DATE:20260415
DTSTAMP:20260404T182037
CREATED:20260125T230946Z
LAST-MODIFIED:20260125T230946Z
UID:10002069-1776038400-1776211199@www.dementiaresearcher.nihr.ac.uk
SUMMARY:The Institute of Clinical Research Conference
DESCRIPTION:We are delighted to announce the ICR 2026 Conference on 13th and 14th April in Birmingham. \nWith the UK implementing the most significant update to clinical trials regulations on April 28\, 2026\, the timing is perfect to join us. Our key focus is to bring together the clinical research community\, to educate the community and of course to promote ICR. We will bring together a number of experts on relevant topics\, and also provide opportunities to network and share knowledge. \nView the Programme \nRegister to Attend
URL:https://www.dementiaresearcher.nihr.ac.uk/event/the-institute-of-clinical-research-conference/
LOCATION:The Birmingham Conference & Events Centre\, Hill Street\, Birmingham\, West Midlands\, B5 4EW\, United Kingdom
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2024/07/The-Institute-of-Clinical-Research.png
GEO:52.4760302;-1.8991255
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=The Birmingham Conference & Events Centre Hill Street Birmingham West Midlands B5 4EW United Kingdom;X-APPLE-RADIUS=500;X-TITLE=Hill Street:geo:-1.8991255,52.4760302
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260413T170000
DTEND;TZID=Europe/London:20260413T180000
DTSTAMP:20260404T182037
CREATED:20260323T213900Z
LAST-MODIFIED:20260323T213900Z
UID:10002157-1776099600-1776103200@www.dementiaresearcher.nihr.ac.uk
SUMMARY:EV-Mediated Microglial Modulation in AD
DESCRIPTION:ISTAART Biofluid Based Biomarkers PIA Webinar – We will highlight how neuronal extracellular vesicles from healthy neurons can reduce inflammation in Alzheimer’s disease by modulating microglial function and promoting homeostasis-like transcriptional states. \nSpeaker: M. Madhy Garcia Garcia \nModerator: Amanpreet Badhwar \n\nRegister\n 
URL:https://www.dementiaresearcher.nihr.ac.uk/event/ev-mediated-microglial-modulation-in-ad/
LOCATION:Online\, United Kingdom
CATEGORIES:Workshop
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2023/01/ISTAART-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260414
DTEND;VALUE=DATE:20260417
DTSTAMP:20260404T182037
CREATED:20251112T200037Z
LAST-MODIFIED:20251114T093825Z
UID:10001746-1776124800-1776383999@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Alzheimer's Disease International Conference 2026
DESCRIPTION:ADI is proud to be highlighting the upcoming Global Conference of ADI in 2026\, taking place 14 – 16 April 2026 in Lyon\, France\, in collaboration with ADI member association France Alzheimer. We invite our global network to join us as we explore innovative approaches\, breakthroughs\, and solutions to shape Alzheimer’s care\, treatment and research for today and tomorrow.   \nIf your research\, innovative solution or activity aligns with the conference abstract themes then we would love to hear from you. \n\nDementia as a public health priority\nDementia awareness\nDementia risk reduction\nDementia diagnosis\, treatment\, care and support\nSupport for dementia carers\nInformation systems for dementia\nDementia research & innovation\n\nWith more abstract themes to be announced soon. \nKey dates for abstract submissions \nAbstract submissions open: Monday\, 2 June 2025 / Abstract submissions close: Friday\, 19 September 2025 \nVisit the Conference Website \n\n\n\nAbstract submissions for ADI 2026 will open on Monday 2 June 2025.\n\n\n\n\nAlzheimer’s Disease International welcomes both scientific and non-scientific abstracts based around the 7 action areas of the WHO Global Action Plan on dementia and the conference theme “Solutions for Today and Tomorrow.” Please see the abstract topics listed below and beneath that\, further details on our abstract guidelines. \nThe scoring criteria has been shaped to reflect ADI’s main priorities for the conference programme. It is important to ADI that content is fresh and innovative\, but also that it clearly demonstrates a consideration for the lives of people with dementia and/or their carers as this is what drives us as an organisation and underpins all of our work. \n\nDementia as a public health priority\n\n\n\n\nDementia\, human rights and equitable society\nDementia policy and plans\nEconomics and value of dementia\nEthics\, finances and laws of dementia NEW!\nEngaging people with dementia and carers in policy\nHealthcare system readiness\n\n\nDementia awareness\n\n\n\n\nAttitudes\, awareness and stigma\nDementia friendliness and inclusivity\nDiverse populations: solutions around inclusion and equality\nEnvironment\, architecture and design for dementia\nThe work of national dementia associations\n\n\nDementia risk reduction\n\n\n\n\nBrain health for life NEW!\nCampaigns shaping the future of dementia prevention\nRisk factors (Physical inactivity\, smoking\, excessive alcohol consumption\, air pollution\, head injury\, infrequent social contact\, less education\, obesity\, hypertension\, diabetes\, depression\, hearing impairment\, untreated vision loss\, elevated LDL levels)\nRisk factors beyond the Lancet Commission (e.g. sleep\, vitamins etc.) NEW!\nRisk reduction and prevention (including clinical trials and lifestyle interventions).\n\n\nDementia diagnosis\, treatment\, care and support\n\n\n\n\nBehavioural and psychological symptoms of dementia\nBiomarkers\nDementia therapies (music\, dance\, art etc.)\nDiagnosis\, diagnostic tools and cognitive assessments\nEnd of life and palliative care\nLiving alone with dementia: research\, innovation and support NEW!\nModels of care (including residential\, end of life and day care)\nPost diagnostic support for people with dementia and carers\nPsychosocial interventions\nRehabilitation\nSupport for people living with dementia\nTreatment experiences of people living with dementia\, carers and clinicians NEW!\nWell being and quality of life\n\n\nSupport for dementia carers\n\n\n\n\nEducation and training for informal carers\nEducation and training for professionals and formal carers\nInformal carers support: pre\, during and post\nMigration and the importance of cultural context for carers/providers\nYoung carers\n\n\nInformation systems for dementia\n\n\n\n\nThe Global Dementia Observatory (GDO)\, international collaboration on data sharing and registries\n\n\nDementia research & innovation\n\n\n\n\nAI and innovation\nAssistive technology (including adaptive and rehabilitative devices) NEW!\nClinical trials\nDementia beyond the amyloid hypothesis (including oral hygiene\, new genes\, gut microbiome\, autoimmune diseases and neuroinflammation) NEW!\nEpidemiology\nInternational collaborations\nLess common dementias and syndromes (including Down Syndrome and childhood dementia)\nLGBTQI+ and dementia\nMild Cognitive Impairment (MCI) NEW!\nNew and future approaches and treatments\nNon-pharmacological interventions\nStages of dementia\nUnderrepresented populations and dementia: exploring sex\, gender\, diversity\, equity and inclusion in dementia research\n\n\n\nAbstract guidelines\n\n\n\n\nIt is important to ADI that presenters’ use dementia friendly language and we would encourage all those submitting an abstract to look at the language guidelines\, created by Dementia Australia in collaboration with people living with dementia. They are to be used when writing your abstract and presenting at ADI conferences\, as well as other conferences about Alzheimer’s disease and other dementias. \n\n\n\n\nIt is important that you as presenters heed these guidelines in your abstract submissions\, and if successful\, in your oral or poster presentations. \nThe following highlights the preferred terms next to the terms we advise submitters not to use when referring to a person with dementia or their family/friend support person \nFull submission guidance \n 
URL:https://www.dementiaresearcher.nihr.ac.uk/event/alzheimers-disease-international-conference-2026/
LOCATION:Palais des congrès de Lyon\, 50 Quai Charles de Gaulle\, Lyon\, 69006\, France
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2020/05/ADI-e1606238565168.png
GEO:45.7850667;4.8536989
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Palais des congrès de Lyon 50 Quai Charles de Gaulle Lyon 69006 France;X-APPLE-RADIUS=500;X-TITLE=50 Quai Charles de Gaulle:geo:4.8536989,45.7850667
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260414T093000
DTEND;TZID=Europe/London:20260414T160000
DTSTAMP:20260404T182037
CREATED:20260305T221321Z
LAST-MODIFIED:20260305T221321Z
UID:10002138-1776159000-1776182400@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Innovation Forum: Place-based health and wellness
DESCRIPTION:This year we’re inviting you to roll-up your sleeves and help us define a place-based approach to healthy ageing. \n\n\n\n\nLast year our first ever Healthy Ageing & Care Innovation Forum brought together pioneers from industry\, academia\, care\, and community sectors to re-examine how we understand healthy ageing\, identity and social connection. This year\, we’re raising the ambition. \nWe’re inviting leading thinkers\, creators\, and partners from across the health tech\, built environment\, and innovation ecosystems to help shape the future of one of the most exciting living labs for healthy ageing in the UK\, situated within The Chocolate Quarter; already a flagship model of intergenerational\, open retirement living. \nOur goal is to explore how we can combine people\, place\, nature\, technology\, and data to prototype new models of healthy ageing and care innovation that can scale regionally\, nationally and globally. \nTogether\, we’ll investigate: \n\nHow people of all ages move through and use these spaces; and how design\, technology and community activation can promote healthier choices and more connected lives\, whilst respecting people’s individual choices.\nThe role of emerging technologies\, smart environments\, and data-driven insights in improving well-being\, resilience and independence.\nHow we create environments that support people living with dementia\, frailty or long-term conditions\, while celebrating movement\, purpose and contribution.\nWhat Somerdale Pavilion\, The Chocolate Quarter and St Monica Trust itself could become over the next 5\, 10\, 15 years; and what interventions\, partnerships and prototypes we should initiate now.\n\nThis is an opportunity to help shape a real world test bed for healthy ageing and care innovation\, rooted in the community but connected to cutting edge research\, innovation and industry. \n\n\n\n\nTake a look at what we got up to at our Innovation Forum last March. \n\n\n\n\n\n\nAgenda\n\n\n\n09:30 AM – 10:00 AM \nWelcome and sign in\nWelcome to our innovation forum 2026. Please sign in on arrival\, settle in and help yourself to refreshments \n\n\n10:00 AM – 10:20 AM \nOpening Remarks\nOpening remarks from David Williams\, CEO of St Monica Trust\, Paul Tisdale\, Director of Villages and Sara Naylor-Wild\, Director of Care \n\n\n10:30 AM – 11:15 AM \nPanel: Integrating Care Into the Wider Research & Innovation Ecosystem\nPanel discussion featuring contributions from: Health Innovation West — regional innovation pipelines and adoption/scale-up pathways. ARCO — sector‑wide insights on integrated retirement communities. NIHR — opportunities for place‑based\, longitudinal and participatory research. National Care Forum — the role of care providers in unlocking social innovation. \n\n\n11:20 AM – 12:00 PM \nRapid Prototyping Workshop: Reimagining Healthy Ageing\nA fast‑paced\, hands‑on session inspired by St Monica Trust’s four pillars: Sleep better\, move more\, stay connected\, live healthy. \n\n\n12:00 PM – 01:00 PM \nLunch\n01:00 PM – 03:00 PM \n\n\nWalking Workshop\nJoin for an immersive activity to think about how people move through our spaces\, how we can enhance and future proof them\, and how we can create a spring board for health focused innovation \n\n\n03:00 PM – 04:00 PM \nFinal reflections and closing remarks\nWe will conclude the day by reflecting on our key insights and sharing recommendations and ideas for St Monica Trust and all attendees. \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/innovation-forum-place-based-health-and-wellness/
LOCATION:Somerdale Pavilion\, Somerdale Pavilion\, Keynsham\, BS31 2FW\, United Kingdom
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/03/St-Monica-Trust.png
GEO:51.4229773;-2.4964451
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Somerdale Pavilion Somerdale Pavilion Keynsham BS31 2FW United Kingdom;X-APPLE-RADIUS=500;X-TITLE=Somerdale Pavilion:geo:-2.4964451,51.4229773
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260415T120000
DTEND;TZID=Europe/London:20260415T124500
DTSTAMP:20260404T182037
CREATED:20260309T150636Z
LAST-MODIFIED:20260309T150636Z
UID:10002141-1776254400-1776257100@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Research Showcase - Dementia & Employment Research Priorities
DESCRIPTION:What support do people living with dementia need to remain in work. How can employers\, policy makers\, researchers\, and carers work together to shape better employment support.\n\nThis livestream is part of the Dementia Researcher weekly Showcase series. Each week we host a 45 minute online session bringing researchers together to share their work\, methods\, and ideas. \nIn this session\, Dr Rachel Allen from the University of West of Scotland present current work from the Working with Dementia Network + project\, which explores dementia and employment across research\, policy\, and practice. The project has recently completed a series of Nominal Group Technique focus groups designed to identify priorities for future work in this area. \nThese groups brought together people living with a dementia diagnosis\, carers\, employers and managers\, professionals involved in policy\, and researchers. Rachel will discuss why this approach was used\, what participants identified as key priorities\, and how these findings will shape the next phase of the Network Plus programme. \nAttendees can expect a research focused session with time for questions and discussion. \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/research-showcase-dementia-employment-research-priorities/
LOCATION:Dementia Researcher Communities App
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/03/Dementia-and-Employment-Research-Priorities-web.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260422
DTEND;VALUE=DATE:20260423
DTSTAMP:20260404T182037
CREATED:20260327T113708Z
LAST-MODIFIED:20260327T113708Z
UID:10002167-1776816000-1776902399@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Replacing in vivo models with complex cellular systems
DESCRIPTION:As regulatory expectations evolve towards inclusion of new approach methodologies (NAMs) in safety assessment and the scientific community focuses on mechanism‑driven discovery research\, this event from ELRIG’s UK Forum offers a timely forum to explore emerging replacement technologies that deliver greater physiological relevance to human biology. \nThrough expert talks\, interactive discussions and technology demonstrations\, attendees will gain a clear understanding of how next‑generation models\, including organoids\, microphysiological systems and co‑culture platforms\, can be integrated into drug discovery pipelines. \nThis one‑day meeting will showcase cutting‑edge advances in complex cellular systems\, animal‑replacement technologies\, and new approach methodologies (NAMs) that are reshaping translational research and reducing reliance on traditional in vivo models. As regulatory expectations evolve and the scientific community accelerates toward human‑relevant\, mechanism‑driven discovery\, the event offers a timely forum for delegates to explore emerging technologies that deliver greater physiological relevance\, improved predictivity\, and enhanced ethical sustainability. Through expert talks\, interactive discussions\, and technology demonstrations\, attendees will gain a clear understanding of how these next‑generation models\, including organoids\, microphysiological systems\, and co‑culture platforms\, can be integrated into discovery pipelines today. \nDelegates will leave with three key learnings: \n\nA critical view of the latest complex cellular\, NAM\, and animal‑replacement systems and their translational value.\nPractical strategies for replacing or reducing animal models while maintaining scientific robustness.\nActionable insights on implementation\, including assay design\, validation considerations\, and operational challenges.\n\nThe programme will deliver: \n\nA critical view of the latest complex cellular models\, NAMs and non-animal technologies and their translational value.\nPractical strategies for replacing or reducing animal models while maintaining scientific robustness.\nActionable insights on implementation\, including assay design\, validation considerations and operational challenges.\n\nAbout ELIRG\nELRIG is a not-for-profit organisation bringing together the global life science and drug discovery industry at open-access\, free-to-attend events. Find out more: elrig.org. \nDr Cathy Vickers (NC3Rs Head of Innovation) is a member of the ELRIG Science Committee and a Director of this ELRIG UK Forum\, alongside Drs Emma Shepard (Aston University)\, Paul Roach (Loughborough University) and Eric Hill (Loughborough University). \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/replacing-in-vivo-models-with-complex-cellular-systems/
LOCATION:Loughborough University\, Epinal Way\, Loughborough\, LE11 3TU\, United Kingdom
CATEGORIES:Training
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/03/ELRIGs-UK-Forum.png
GEO:52.7679306;-1.2227527
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Loughborough University Epinal Way Loughborough LE11 3TU United Kingdom;X-APPLE-RADIUS=500;X-TITLE=Epinal Way:geo:-1.2227527,52.7679306
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260422T090000
DTEND;TZID=Europe/London:20260422T190000
DTSTAMP:20260404T182037
CREATED:20260302T135231Z
LAST-MODIFIED:20260302T135231Z
UID:10002128-1776848400-1776884400@www.dementiaresearcher.nihr.ac.uk
SUMMARY:UCL Advanced Therapies Symposium 2026
DESCRIPTION:The UCL Advanced Therapies Symposium is a flagship event showcasing UCL’s world-leading expertise and multidisciplinary approach to transforming healthcare through advanced therapies. This one-day\, in-person gathering brings together over 250 UCL scientists\, clinical collaborators\, funding bodies\, and industry leaders to explore cutting-edge research and its journey from bench to bedside. \nThe 2026 programme will spotlight CAR-T therapy (autoimmune conditions)\, rare disease gene therapy\, cell therapy and strategies for commercialising innovations from lab to market. Alongside keynote talks and panel discussions\, the symposium will feature talks and poster presentations by early career researchers\, offering fresh perspectives on novel therapeutics and emerging technologies. Delegates will gain insights into UCL’s pioneering work\, clinical applications\, and strategic partnerships\, while networking sessions throughout the day provide invaluable opportunities to connect with experts and foster collaborations across the therapeutic innovation ecosystem. \nCoinciding with UCL’s bicentennial celebrations in 2026—and building on a 200-year legacy of research and innovation—this year’s symposium invites you to explore new collaborations and be part of the effort to advance therapies for the future. \nDate: Wednesday 22 April 2026\nTime: Registration 09.00-9.20; Seminar 9.20-17.30; Networking Reception 17.30-19.00\nOpen to: UCL staff and students\, UCL BRCs*\, and external partners\nVenue: Kennedy Lecture Theatre\, UCL Great Ormond Street Institute of Child Health\, 30 Guilford Street London WC1N 1EH  (Google Map\, Local area map and transportation)\nProvisional agenda: view here \nTickets:\nUCL staff and students; UCL BRCs* – Free registration with UCL email address or designated BRC work email address (If you find that they are currently sold out\, please sign up for the waitlist. We often release more spots as registrants drop out\, so we will notify those on the list as soon as tickets become available.)\nNon-UCL delegates – Early bird offer for £50 (available until 11 March 2026; automatically applied at checkout). Full price: £75;\nNon-UCL academics and public sector – £25\nAll prices are VAT inclusive.\n*UCL BRCs refer to: NIHR UCLH Biomedical Research Centre; NIHR Moorfields Biomedical Research Centre; NIHR Great Ormond Street Hospital Biomedical Research Centre. \nTo stay updated: \nSign up to the mailing list to receive updates about the symposium. \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/ucl-advanced-therapies-symposium-2026/
LOCATION:UCL – Kennedy Lecture Theatre\, Institute of Child Health - Main Building\, 30 Guildford Street\, London\, Greater London\, WC1N 1EH\, United Kingdom
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/01/UCL-Logo-2025.png
GEO:51.523309;-0.120066
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=UCL – Kennedy Lecture Theatre Institute of Child Health - Main Building 30 Guildford Street London Greater London WC1N 1EH United Kingdom;X-APPLE-RADIUS=500;X-TITLE=Institute of Child Health - Main Building\, 30 Guildford Street:geo:-0.120066,51.523309
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260422T120000
DTEND;TZID=Europe/London:20260422T124500
DTSTAMP:20260404T182037
CREATED:20260313T103432Z
LAST-MODIFIED:20260313T104240Z
UID:10002151-1776859200-1776861900@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Research Showcase - Blood Biomarkers for Alzheimer’s Across Diverse Communities
DESCRIPTION:Can Alzheimer’s disease blood biomarkers work equally well across all populations. And how acceptable are these tests for communities that have historically been under represented in research. \nThis livestream is part of the Dementia Researcher weekly Showcase series. Each week we host a 45 minute online session bringing researchers together to share their work\, methods\, and ideas. \nIn this session\, Natalia Chemas will present research from her NIHR funded doctoral fellowship exploring the diagnostic validity of Alzheimer’s disease blood biomarkers in ethnic minority groups. Her work examines whether these emerging diagnostic tools perform consistently across different populations and explores how acceptable this testing approach is for diverse communities. \nNatalia is a PhD student at Queen Mary University of London working within the dementia research team at the Centre for Psychiatry and Neuroscience. She completed a Psychology BSc in Colombia and a Mental Health Sciences MSc at University College London\, and has experience supporting research studies across academia\, the NHS\, and industry. \nHer doctoral research is supervised by Charles Marshall\, Claudia Cooper\, and Ashvini Keshavan and focuses on improving equitable access to emerging diagnostic approaches in Alzheimer’s disease. \nAttendees can expect a research focused session with time for questions and discussion. \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/research-showcase-blood-biomarkers-for-alzheimers-across-diverse-communities/
LOCATION:Dementia Researcher Communities App
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/03/Blood-Biomarkers-for-Alzheimers-Across-Diverse-Communities-web.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260422T130000
DTEND;TZID=Europe/London:20260422T150000
DTSTAMP:20260404T182037
CREATED:20260323T110148Z
LAST-MODIFIED:20260323T110148Z
UID:10002155-1776862800-1776870000@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Data Sharing in Dementia Research
DESCRIPTION:Alzheimer Europe Research Insights\, a public webinar series focused on new developments and topics in research. Research Insights are interactive webinars bringing together academic and industry researchers\, clinicians\, national Alzheimer organisations\, policymakers and the wider dementia community\, to exchange knowledge on cross-cutting research topics. Through these\, Alzheimer Europe aims to increase the visibility and impact of European research projects\, support collaboration across consortia\, and raise awareness of research developments in the European dementia community. \nEach session will be hosted on Zoom\, moderated by Alzheimer Europe\, and will combine short presentations from selected projects and initiatives with a panel discussion and audience Q&A. Recordings will be made publicly available afterwards\, via Alzheimer Europe’s YouTube channel. \nOur first Research Insights session will take place on 22 April from 14.00 to 16.00 CET and address the what\, why and how of data sharing in dementia research\, illustrating practical approaches\, platforms and use cases\, alongside perspectives from lived experience. Data sharing can make better use of existing datasets\, support collaboration across disciplines and countries\, and speed up progress in dementia research – but it also raises challenges linked to data protection\, technical barriers and differences in how data are managed. \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/data-sharing-in-dementia-research/
LOCATION:Online\, United Kingdom
CATEGORIES:Workshop
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2021/07/Alzheimer-Europe-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260422T140000
DTEND;TZID=Europe/London:20260422T151500
DTSTAMP:20260404T182037
CREATED:20260327T111108Z
LAST-MODIFIED:20260327T111108Z
UID:10002164-1776866400-1776870900@www.dementiaresearcher.nihr.ac.uk
SUMMARY:NAMs Technology Partn3Ring webinar
DESCRIPTION:The first NAMs webinar will include presentations from researchers working across invertebrate models as partial replacements for the use of mammals\, human-relevant microphysiological models\, drug efficacy and drug/consumer product toxicity testing. \nEarly drug screening with C. elegans: A 3Rs-aligned approach \nSara Leighton (Magnitude Biosciences Limited)\n•    High-throughput C. elegans platform\, delivering scalable and predictive insights on drug efficacy\, safety and mechanism of action.\n•    Seeking collaborators to further qualify screening platform and provide access to comparator datasets. \nFrom model to method: Validating C. elegans-based DART assay towards regulatory use \nEva Martini (Nagi Bioscience)\n•    Providing human relevant whole organism toxicity data that can replace early mammalian screens.\n•    Seeking collaborators for new toxicology use cases\, cross‑species comparison\, and standardisation towards regulatory readiness. \nTitle TBC\nMargaret Magdesian (Ananda Devices)\n•    Developing human iPSC‑based neuro and neuromuscular assays towards replacing animal use in neurotoxicity assays.\n•    Seeking partners to benchmark and expand applications\, including exploring incorporation into regulatory workflows. \nTitle TBC\nVitaliy Khutoryanskiy (University of Reading)\n•    Developing invertebrate assays that can replace early-stage mammalian studies in toxicity\, irritation\, infection and formulation screening.\n•    Seeking collaborators interested in co-developing and qualifying the invertebrate-based assays for broader application and increased translational relevance. \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/nams-technology-partn3ring-webinar/
LOCATION:Online\, United Kingdom
CATEGORIES:Online
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2023/03/NC3Rs-Logo.png
ORGANIZER;CN="NC3Rs":MAILTO:enquiries@nc3rs.org.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260423
DTEND;VALUE=DATE:20260424
DTSTAMP:20260404T182037
CREATED:20260203T162016Z
LAST-MODIFIED:20260203T162016Z
UID:10002082-1776902400-1776988799@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Vivensa Foundation Annual Symposium
DESCRIPTION:The Vivensa Foundation Annual Symposium will be taking place on 23rd April 2026 at the IET\, 2 Savoy Place London. Further details can be found below and registration is via Eventbrite. \nThe event is free to attend. To register\, the deadline is Monday\, 6th April 2026. As part of the registration process\, we are offering attendees the opportunity to nominate themselves for a poster presentation. We’ll be reviewing and selecting titles/abstracts to ensure a diverse range of topic areas\, career stages and presenters are represented. \nThe deadline to submit a title and abstract for a poster is 20th March 2026. \nGiven the limited space available for posters\, priority will be given to those from projects funded by the Vivensa Foundation. We will notify all applicants in advance to confirm whether their poster has been selected for presentation at the event. \nDeadlines: \nPoster Submission Deadline: 20th March 2026\nEvent Registration Deadline: 6th April 2026 \nWe plan to make recordings of the event available on our website for those unable to attend. \nIf you have any questions or need further information\, please don’t hesitate to contact us at admin@vivensafoundation.org.uk. \n**We will also aim to cover the costs of travel to the event for early career researchers\, where there is no other means to claim these back. Priority of any available funds will be given to Vivensa Foundation-funded ECRs and/or those selected to present at the event – attendees intending to claim travel costs should confirm these with the Foundation prior to booking travel. If you have any questions about this\, or the event in general\, please email admin@vivensafoundation.org.uk
URL:https://www.dementiaresearcher.nihr.ac.uk/event/vivensa-foundation-annual-symposium/
LOCATION:IET\, 2 Savoy Place\, London\, WC2R 0B\, United Kingdom
CATEGORIES:Symposium
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/01/Vivensa-Foundation.png
GEO:51.5100099;-0.1192623
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=IET 2 Savoy Place London WC2R 0B United Kingdom;X-APPLE-RADIUS=500;X-TITLE=2 Savoy Place:geo:-0.1192623,51.5100099
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260423T100000
DTEND;TZID=Europe/London:20260423T163000
DTSTAMP:20260404T182037
CREATED:20260220T150019Z
LAST-MODIFIED:20260218T115311Z
UID:10002115-1776938400-1776961800@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Vivensa Foundation 2026 Annual Symposium
DESCRIPTION:Join The Vivensa Foundation to hear about the fantastic initiatives we have been supporting and meet our 2026 Excellence Award winners. \n\n\n\n\nJoin us in-person 10.00-16.30 on Thursday 23rd April 2026 at the the IET in London for our annual symposium.\nOur theme this year is “evidence into practice” and we will also be announcing the winners of this year’s Vivensa Academy Excellence Awards. \nThe event is free to attend**. To register\, the deadline is Monday 6th April 2026. As part of the registration process\, we are offering attendees the opportunity to nominate themselves for a poster presentation and/or a speaking slot in the ‘5-minute research showcase’ section of the agenda. We’ll be reviewing and selecting titles/abstracts to ensure a diverse range of topic areas\, career stages and presenters are represented. The deadline to submit a title and abstract for a poster is 20th March 2026. Given the limited space available for speaking/posters slots\, priority will be given to those from projects funded by the Vivensa Foundation. We will notify all attendees in advance to confirm whether their abstract has been selected for a poster or talk. \nDeadlines: \nTitle/Abstract Submission Deadline: 20th March 2026\nEvent Registration Deadline: 6th April 2026 \nIf you have any questions or need further information\, please don’t hesitate to contact us at admin@vivensafoundation.org.uk \n**We will also aim to cover the costs of travel to the event for early career researchers (ECRs)\, where there is no other means to claim these back. Priority of any available funds will be given to Vivensa Foundation-funded ECRs and/or those selected to present at the event – attendees intending to claim travel costs should confirm these with the Foundation prior to booking travel. If you have any questions about this\, or the event in general\, please email admin@vivensafoundation.org.uk \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/vivensa-foundation-2026-annual-symposium/
LOCATION:IET\, 2 Savoy Place\, London\, WC2R 0B\, United Kingdom
CATEGORIES:Symposium
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/01/Vivensa-Foundation.png
GEO:51.5100099;-0.1192623
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=IET 2 Savoy Place London WC2R 0B United Kingdom;X-APPLE-RADIUS=500;X-TITLE=2 Savoy Place:geo:-0.1192623,51.5100099
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260424T150000
DTEND;TZID=Europe/London:20260424T160000
DTSTAMP:20260404T182037
CREATED:20260327T121412Z
LAST-MODIFIED:20260327T121412Z
UID:10002169-1777042800-1777046400@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Rethinking ARIA: Antibody Amplified CAA-ri?
DESCRIPTION:Explore new insights into ARIA and CAA in anti amyloid therapies\, examining how antibodies may amplify CAA related inflammation and what this reveals about underlying disease mechanisms – in this webinar organised by the ISTAART Vascular Cognitive Disorders PIA. \nThis session will also highlight emerging biomarker evidence that is reshaping how we interpret the pathophysiology of these conditions and their implications for treatment safety and monitoring. \nBringing together leading expertise\, the discussion will consider how advances in imaging and fluid biomarkers are helping to identify risk\, track progression and better understand patient variability in response to therapy. Expect a focused exploration of how these findings could influence clinical decision making and future therapeutic development. \nSpeakers: Cynthia Lemere\, Fabrizio PiazzaModerators: Beth Eyre\, Roxana Carare \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/rethinking-aria-antibody-amplified-caa-ri/
LOCATION:Online\, United Kingdom
CATEGORIES:Workshop
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2023/01/ISTAART-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260427T160000
DTEND;TZID=Europe/London:20260427T170000
DTSTAMP:20260404T182037
CREATED:20260323T223943Z
LAST-MODIFIED:20260323T223943Z
UID:10002159-1777305600-1777309200@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Capturing Inflammaging with Omics
DESCRIPTION:ISTAART Design and Data Analytics PIA Webinar – Dr. Meir will illustrate how moving from traditional blood markers to single omics and integrated multi-omics approaches refines our understanding of inflammatory aging across biological scales and social contexts. \nModerator: Ana Capuano \nSpeaker: Anat Yaskolka Meir \n\nRegister\n 
URL:https://www.dementiaresearcher.nihr.ac.uk/event/capturing-inflammaging-with-omics/
LOCATION:Online\, United Kingdom
CATEGORIES:Workshop
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2023/01/ISTAART-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260428T150000
DTEND;TZID=Europe/London:20260428T160000
DTSTAMP:20260404T182037
CREATED:20260331T114504Z
LAST-MODIFIED:20260331T114504Z
UID:10002174-1777388400-1777392000@www.dementiaresearcher.nihr.ac.uk
SUMMARY:ISTAART Technology PIA: Meet the Author
DESCRIPTION:How can artificial intelligence help clinicians better distinguish between different types of dementia. And what happens when we combine multiple data sources to improve diagnostic accuracy. \nThis ISTAART Technology and Dementia PIA Journal Club brings together early career researchers and established experts to explore how multimodal AI is shaping the future of dementia diagnosis. \nIn this session\, Sol Morrissey will present research on AI based differential diagnosis of dementia etiologies using multimodal data. The work explores how combining imaging\, clinical\, and other datasets can improve diagnostic precision and support clinical decision making. \nFollowing the presentation\, author Vijaya Kolachalama will join for a live Q and A\, offering additional insight into the research and its implications for practice and future study. \nThe session is moderated by Sayeh Bayat and is designed to encourage discussion\, questions\, and shared learning across disciplines. \nSpeakers\n\nSol Morrissey\, Schulich School of Engineering\, University of Calgary\, Canada\nVijaya Kolachalama\, Boston University\, United States\nSayeh Bayat\, University of Calgary\, Canada\n\nWhat to Expect\n\nA trainee led presentation on multimodal AI in dementia diagnosis\nInsight into combining diverse data sources for clinical use\nLive discussion with the study author\nOpportunities for questions and shared perspectives\n\nEvent Details\n\nDate: Tuesday 28 April\nTime: 9:00 a.m. Central Time\nFormat: Online webinar\n\n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/istaart-technology-pia-meet-the-author/
LOCATION:Online\, United Kingdom
CATEGORIES:Workshop
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2023/01/ISTAART-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260428T190000
DTEND;TZID=Europe/London:20260428T200000
DTSTAMP:20260404T182037
CREATED:20260305T223143Z
LAST-MODIFIED:20260305T223143Z
UID:10002139-1777402800-1777406400@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Sex and APOE4 Interaction in Alzheimer's Disease
DESCRIPTION:Join The ISTAART Sex and Gender Differences in Alzheimer’s Disease PIA for its next webinar titled\, The Interaction Between Sex and APOE4 in Alzheimer’s Disease. \nTwo speakers will feature innovative\, trainee-led presentations highlighting recent developments across this topic. \nModerators: \n\nClara Gallay\, Ph.D. Student; BarcelonaBeta Brain Research Center\, Spain\nMabel Seto\, Ph.D.; Harvard University\, United States\nShireen Sindi\, Ph.D.; Karolinska Institute\, Sweden\n\nSpeakers: \n\nMuge Akinci\, Ph.D.; Columbia University Irving Medical Center\, United States – Sex Differences in Alzheimer Disease Imaging Biomarkers in a Diverse\, Community-Based Cohort\nBonnie Lee\, Ph.D.; University of British Columbia\, Canada – Exploring the parity paradox: Differential effects on neuroplasticity and inflammation by APOEe4 genotype at middle age\n\nSign up here and join us on Tuesday\, April 28 at 1 p.m. C.T. \nInterested in joining a Work Group (WG)? Sign up here. \n\nSex Differences in NSS Work Group\nSex Differences in Sleep and AD\nWomen-Specific Alzheimer’s Disease Risk
URL:https://www.dementiaresearcher.nihr.ac.uk/event/sex-and-apoe4-interaction-in-alzheimers-disease/
LOCATION:Online\, United Kingdom
CATEGORIES:Online
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2023/01/ISTAART-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260429T170000
DTEND;TZID=Europe/London:20260429T180000
DTSTAMP:20260404T182037
CREATED:20260215T095856Z
LAST-MODIFIED:20260215T095856Z
UID:10002109-1777482000-1777485600@www.dementiaresearcher.nihr.ac.uk
SUMMARY:LBD PIA: ISTAART Journal Club - Meet the Author
DESCRIPTION:BD PIA ISTAART Journal Club\nMeet the Author\n🗓 29 April 2026🕔 5.00 pm London time📍 Online \nJoin the Lewy Body Dementia Professional Interest Area of ISTAART for a special Meet the Author edition of the Journal Club. This session will explore two important recent papers examining biomarker differences and clinical features in Lewy body dementia. \nNeuroimaging and Plasma Biomarker Differences and Commonalities in LBD Subtypes\nPresented by Kiran AftabFollowed by a live Q and A with authors Naomi Hannaway and Rimona Weil \nCore Clinical Features Associated with Survival in Patients with DLB\nPresented by Felipe Botero RodriguezFollowed by a live Q and A with authors Tanis Ferman and Stuart J McCarter \nThis is an opportunity to hear directly from researchers behind the work\, ask questions\, and discuss findings with colleagues interested in Lewy body dementia research and care. \nWhether you focus on biomarkers\, clinical progression\, or broader dementia research\, this session offers valuable insight into current developments in LBD. \nRegister to Attend
URL:https://www.dementiaresearcher.nihr.ac.uk/event/lbd-pia-istaart-journal-club-meet-the-author/
LOCATION:Online\, United Kingdom
CATEGORIES:Workshop
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2023/01/ISTAART-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260430
DTEND;VALUE=DATE:20260501
DTSTAMP:20260404T182037
CREATED:20260215T095524Z
LAST-MODIFIED:20260215T095524Z
UID:10002108-1777507200-1777593599@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Families for the Treatment of Hereditary MND (FaTHoM)
DESCRIPTION:Families for the Treatment of Hereditary MND (FaTHoM) is an initiative to bring together the community of families affected by inherited (genetic) forms of MND. \nWith meetings and events consisting of expert talks on key issues affecting such families\, FaTHoM is open to any person living with an inherited form of MND\, and the close relatives of those affected by inherited forms of the disease. \nA dedicated day for those affected by genetic forms of MND and their wider families. An opportunity to learn about current and future trials and research from leading neurologists and researchers\, and to meet with other families from around the country living with hereditary MND in a friendly and supportive educational environment. \nFaTHoM Day\, 2026 will take place on Thursday\, April 30th 2026 at the Milton Hill House Hotel\, Abingdon\, Oxfordshire.  \nThis event is free of charge\, and a maximum of four people per family may attend (aged over 18). The event is limited to 100 attendees. \nTo register TO ATTEND\, please CLICK HERE: \nFor further information on FaTHoM Day\, please email: MNDResearch@ndcn.ox.ac.uk
URL:https://www.dementiaresearcher.nihr.ac.uk/event/families-for-the-treatment-of-hereditary-mnd-fathom/
LOCATION:Milton Hill House Hotel\, Мilton Hill\, Steventon\, Milton\, OX13 6AF\, United Kingdom
CATEGORIES:Public Discussion
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2023/08/University-of-Oxford-Logo.png
GEO:51.6084327;-1.3157743
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Milton Hill House Hotel Мilton Hill Steventon Milton OX13 6AF United Kingdom;X-APPLE-RADIUS=500;X-TITLE=Мilton Hill\, Steventon:geo:-1.3157743,51.6084327
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260430
DTEND;VALUE=DATE:20260502
DTSTAMP:20260404T182037
CREATED:20260213T120017Z
LAST-MODIFIED:20260212T223901Z
UID:10002105-1777507200-1777679999@www.dementiaresearcher.nihr.ac.uk
SUMMARY:AFTD 2026 Education Conference
DESCRIPTION:The AFTD 2026 Education Conference is coming to the Hyatt Regency Lake Washington in Seattle on April 30 – May 1\, 2026. A free livestream will also be available for those who can’t attend in person. \nPeople diagnosed\, care partners\, families\, friends\, healthcare professionals\, and researchers are invited to connect with people who understand the journey\, learn about available resources and supports\, and engage with experts to gain insight on the latest in FTD research and approaches to care. \nRegister to Attend
URL:https://www.dementiaresearcher.nihr.ac.uk/event/aftd-2026-education-conference/
LOCATION:Hyatt Regency Lake\, 1053 Lake Washington Blvd N.\, Renton\, WA\, WA 98056\, United States
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2023/01/AFTD-Logo.png
GEO:47.5030379;-122.205233
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Hyatt Regency Lake 1053 Lake Washington Blvd N. Renton WA WA 98056 United States;X-APPLE-RADIUS=500;X-TITLE=1053 Lake Washington Blvd N.:geo:-122.205233,47.5030379
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260430T110000
DTEND;TZID=Europe/London:20260430T170000
DTSTAMP:20260404T182037
CREATED:20260128T185437Z
LAST-MODIFIED:20260128T185437Z
UID:10002056-1777546800-1777568400@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Nominations are open for The UK Dementia Awards 2026!
DESCRIPTION:The Dementia Community is excited to present a refreshed 2026 Awards programme that celebrates learning\, sharing\, and inspiring across the dementia community. With a streamlined set of 15 awards\, we’re recognising excellence across care\, innovation\, research and lived experience celebrating the dedication\, creativity\, and compassion that drive real change. \nGala Awards Lunch and Ceremony\nOur gala lunch award celebration is rooted in connection and community. Far from the glitz and glamour of typical awards nights\, this event fosters a heartfelt atmosphere where stories are shared\, achievements are genuinely acknowledged\, and people\, including those with lived experience\, come together to appreciate the work that truly matters. It’s a space for recognising achievement with authenticity—where the focus is on impact and where everyone leaves feeling re-energised and truly valued for the difference they make in the dementia community. \nVisit https://journalofdementiacare.co.uk/awards to find out more and make your nomination(s)! Nominations close on Friday 27 February 2026\, 5pm (UK time) \nRegister to Attend
URL:https://www.dementiaresearcher.nihr.ac.uk/event/nominations-are-open-for-the-uk-dementia-awards-2026/
LOCATION:Coombe Abbey Hotel\, Brinklow Rd\, Binley\, Coventry\, CV3 2AB\, United Kingdom
CATEGORIES:Public Discussion
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/01/2026-UK-Dementia-Awards.png
ORGANIZER;CN="Dementia Community":MAILTO:info@dementiapublishing.community
GEO:52.4055565;-1.4286928
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Coombe Abbey Hotel Brinklow Rd Binley Coventry CV3 2AB United Kingdom;X-APPLE-RADIUS=500;X-TITLE=Brinklow Rd\, Binley:geo:-1.4286928,52.4055565
END:VEVENT
END:VCALENDAR